Evaluation of safety and efficacy of 19CP02 combined with cyclophosphamide and fludarabine phosphate in adults with treatment‑refractory active systemic lupus erythematosus

Registered drugNo placebo

Evaluation of safety and efficacy of 19CP02 combined with cyclophosphamide and fludarabine phosphate in adults with treatment‑refractory active systemic lupus erythematosus

Registered drugNo placebo

Belgium

Participants:18–64 years
Substances:Cyclophosphamide
Sponsor:Galapagos

Contact Research Centre

Systemic lupus erythematosus+1

Not recruiting

Evaluation of Long-term Safety and Efficacy of Enpatoran in Subacute Cutaneous, Discoid, and Systemic Lupus Erythematosus Post-WILLOW Study Completion

InvestigationalNo placebo

Evaluation of Long-term Safety and Efficacy of Enpatoran in Subacute Cutaneous, Discoid, and Systemic Lupus Erythematosus Post-WILLOW Study Completion

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Enpatoran
Sponsor:Merck Healthcare KGaA

Contact Research Centre

Substances studied in this area

The therapies tested most often in Musculoskeletal and connective tissue disorders trials.

Sodium Chloride47 clinical trials Paracetamol32 clinical trials Tocilizumab29 clinical trials Methotrexate25 clinical trials Adalimumab24 clinical trials Rituximab23 clinical trials Cyclophosphamide20 clinical trials Etanercept20 clinical trials Baricitinib17 clinical trials

Musculoskeletal and connective tissue disorders – page 44

Conditions in this area

Clinical trials in Musculoskeletal and connective tissue disorders

865 clinical trials

Systemic lupus erythematosus

Study on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)

Axial spondyloarthritis

Study on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis

Systemic sclerosis pulmonary+1

Study on Vixarelimab for Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease

Systemic lupus erythematosus

Study on the Safety and Effectiveness of ESK-001 for Adults with Systemic Lupus Erythematosus

Sjogren's syndrome

Study on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome

Axial spondyloarthritis

Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Axial Spondyloarthritis

Dermatomyositis+3

Phase 2 Study of Daxdilimab with Prednisone in Adults with Inadequately Controlled Dermatomyositis or Anti‑Synthetase Inflammatory Myositis

Systemic sclerosis pulmonary

Tulisokibart in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

Rheumatoid arthritis

Baricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis

Pain+1

A study to compare how the body absorbs celecoxib oral suspension and celecoxib capsules in healthy adults for the treatment of acute pain.

Systemic lupus erythematosus

Evaluation of safety and efficacy of 19CP02 combined with cyclophosphamide and fludarabine phosphate in adults with treatment‑refractory active systemic lupus erythematosus

Systemic lupus erythematosus+1

Evaluation of Long-term Safety and Efficacy of Enpatoran in Subacute Cutaneous, Discoid, and Systemic Lupus Erythematosus Post-WILLOW Study Completion

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.